Omar Boraie has continued to play a fundamental role in bettering the lives New Brunswick residents. In an article published by Newswire on October 21st, 2015, the real estate mogul pledged to donate $1.5 million towards a medical research at Rutgers Cancer Institute of New Jersey. His commitment to the funding the research led to the establishment of the Omar Boraie Chair in Genomic Science. The creation of the Omar Boraie Chair (http://patch.com/new-jersey/newbrunswick/omar-boraie-chair-genomic-science-established-rutgers-cancer-institute) was part of ’18 Chair Challenge’ campaign of the Rutgers University, which will match an anonymous donor’s $ 1.5 million resulting to a $3 million bequest.
Genomic science and precision medicine offer a new platform, which changes the way cancer id diagnosed and treated. It is a new field that seeks to analyze and treat tumors at genetic levels. This will enable oncologists to prescribe tailored and data based therapies for better treatment. The importance of precision medicine and genomic science is of paramount importance to the United States and the world as a whole. This is proved by the launch of National Precision Medicine to focus on finding the cure for cancer and other diseases.
Rutgers Commitment towards Cancer Treatment
Rutgers Cancer Institute emerged uniquely as the first institution to in the country to apply genomic sequencing as a precision medical approach to patient treatment. Genomic sequencing is important in finding unique and innovative therapies for patients with poor prognoses, rare cancer and those with limited or ineffective treatment options. Incorporation of precision medicine in genomic science increases the accuracy of classifying cancer into subgroups with similar characteristic but different genetics. This classification doesn’t help only in predicting precise patient outcomes but also in determining personalized cancer therapy.
The Rutgers Cancer Institute highly appreciated the role played by Omar Boraie in ensuring that New Brunswick remains a healthy city. His relentless efforts in supporting an endowed chair will have a significant impact on cancer research and treatment.
Dr. Shridar Ganesan, an internationally recognized oncologist, was named the Omar Boraie Chair in Genomic Science. A cording to the experienced oncologist, oncologists have learned that cancer is a collection of diseases as opposed to being one disease. Genomic science is, therefore, helpful in analyzing the changes present in each cancer providing precise and individualized therapy. He said that the donation would be of great help in innovating medical research to enable physicians to understand the cancer biology that will give hope to cancer patients.
About Omar Boraie
Omar Boraie is an Egyptian-born American real estate developer. He is the CEO and founder of Boraie Development (https://www.bloomberg.com/profiles/companies/0601263D:US-boraie-development-llc). Foy years, he has been recognized by the New Brunswick, NJ, residents for his unquenchable thirst for charitable causes.
For more information about the Omar Boraie Chair establishment, visit http://newswise.com/articles/omar-boraie-chair-in-genomic-science-established-at-rutgers-cancer-institute